Patent ID: 9730976
Date: 2017-08-15
CPC Classifications: A61K,A61P,C07D,C07K

Claim:
1. A method of treating cancer in a mammalian subject, wherein the cancer is breast cancer, ovarian cancer, acute myeloid leukemia (AML), or prostate cancer characterized by overexpression of an inhibitor of apoptosis protein (IAP) family member, said method comprising administering to the mammalian subject a compound of formula (I) or pharmaceutically acceptable salt thereof, wherein n is 1 or 2 m is an integer from 0 to 3 A is NR R R B is Y is selected among OR R R L is a linker, wherein the linker is wherein unless otherwise indicated, an “optionally substituted” moiety is one that is optionally substituted by alkyl, cycloalkyl, aryl, alkylaryl, OR